← Evidence map

ArticleContraception2019

Corrigendum to "Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women" [Contraception 99 (2019) 199-204].

Renee Heffron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Corrigendum to "Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women" [Contraception 99 (2019) 199-204]. | OpenQuestion